Senescent Macrophages Promote Age‐Related Revascularization Impairment by Increasing Antiangiogenic VEGF ‐ A165B Expression
Aging Cell · 2025
DOI: 10.1111/acel.70059 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging Cell, 2025. Verfasst von Minghong Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatric Medicine, Xiangya Hospital, Central South University, Changsha, Hunan, China. Hauptthemen laut MEDLINE: Macrophages, Vascular Endothelial Growth Factor A, Aging, Cellular Senescence. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for Central Universities of the Central South University.
Abstract (Originalsprache)
Peripheral arterial disease is a common vascular disease in the elderly. Therapeutic revascularization, including angiogenic and arteriogenic therapy, is a promising treatment approach for peripheral arterial disease. However, the progress of clinical trials is not ideal, possibly due to insufficiency of preclinical models, such as not taking into account the effect of aging on vascular regeneration. Macrophages are crucial in angiogenesis and arteriogenesis. The aging microenvironment typically makes recruited monocytes and macrophages more susceptible to senescence. However, the feature of macrophages in ischemic hindlimb muscle of old individuals and their underlying role remains unclear. In this study, we reveal that macrophages of ischemic skeletal muscle in old mice are more senescent and proinflammatory. By transplanting macrophages into mice following hindlimb ischemia, we find senescent macrophages inhibit revascularization. Mechanistically, these senescent macrophages induce endothelial dysfunction via increasing vascular endothelial growth factor A‐165B (VEGF‐A165B) expression and secretion, and eventually impair revascularization. Notably, plasma VEGF‐A165B levels are elevated in old patients with PAD and positively associated with a lower ankle brachial index (ABI). Our study suggests that targeting the senescent macrophages presents an avenue to improve age‐related revascularization damage.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Geriatric Medicine, Xiangya Hospital, Central South University, Changsha, Hunan, China.
- Center of Coronary Circulation, Xiangya Hospital, Central South University, Changsha, Hunan, China.
- National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, China.
- Department of General and Vascular Surgery, Xiangya Hospital, Central South University, Changsha, Hunan, China.
- Department of Cardiology, Qilu Hospital of Shandong University, Jinan, Shandong, China.
- Department of Child Health Care, Hunan Provincial Maternal and Child Health Care Hospital, Changsha, Hunan, China.
ORCID-Profile: Qun Huang
Förderung
- National Natural Science Foundation of China
- Fundamental Research Funds for Central Universities of the Central South University
Zitieren
APA
Chen, M., Chen, J., Liu, Y., Wang, X., Yao, M., Chen, J., Zhang, J., & Huang, Q. (2025). Senescent Macrophages Promote Age‐Related Revascularization Impairment by Increasing Antiangiogenic VEGF ‐ A165B Expression. Aging Cell. https://doi.org/10.1111/acel.70059
Vancouver
Chen M, Chen J, Liu Y, Wang X, Yao M, Chen J, et al. Senescent Macrophages Promote Age‐Related Revascularization Impairment by Increasing Antiangiogenic VEGF ‐ A165B Expression. Aging Cell. 2025. doi:10.1111/acel.70059
BibTeX
@article{Chen2025,
author = {Chen, Minghong and Chen, Junyu and Liu, Yu and Wang, Xuerui and Yao, Meilian and Chen, Jing and Zhang, Jian and Huang, Qun},
title = {Senescent Macrophages Promote Age‐Related Revascularization Impairment by Increasing Antiangiogenic VEGF ‐ A165B Expression},
journal = {Aging Cell},
year = {2025},
doi = {10.1111/acel.70059}
}
EUVIMED